Home » Topics » BioWorld

BioWorld
RSS

CAMBRIDGE NEURO SBIR FOR HEART SURGERY COMPOUND

Sep. 6, 1991

BIOCRYST GETS SBIR FOR FLU TREATMENT

Sep. 6, 1991

LIDAK GETS SBIR FOR FREE FATTY ACID ASSAY

Sep. 6, 1991

IMMUNOGEN STARTS EUROPEAN CLINICALS

Sep. 6, 1991

CYTEL INVESTIGATES WHITE CELLS AND TARGETS

Sep. 6, 1991

GM-CSF ALTERNATIVE TO BONE MARROW TRANSPLANT

Sep. 6, 1991

CENTOXIN LABEL MAY DETERMINE MARKET SIZE

Sep. 6, 1991

MARROW-TECH TO USE SBIR FOR DERMAGRAFT RESEARCH

Sep. 6, 1991

THERATECH TO COLLABORATE WITH SYNTEX

Sep. 6, 1991

INNOVET TO LICENSE IMMUNE STIMULANT

Sep. 5, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...